Skip to Main Content

Paper Details

Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331.
J Clin Oncol
18
2021
-, -ALL, ALL, B, B-ALL, B-Cell Acute Lymphoblastic Leukemia, B-acute lymphoblastic leukemia, Cancer, Children, ETV6, Low-, RUNX1, RUNX1 fusion, Trisomies, WBC, children, low-, marrow blasts, patients, pegaspargase
Author NameAffiliation
Meenakshi DevidasSt Jude Children's Research Hospital
Julie M Gastier-FosterNationwide Children's Hospital, Ohio State University College of Medicine
Julie M Gastier-FosterOhio State University College of Medicine
Julie M Gastier-FosterNationwide Children's Hospital, Ohio State University College of Medicine
Julie M Gastier-FosterOhio State University College of Medicine
Mignon L LohBenioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Stephen P HungerDepartment of Pediatrics and The Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at The University of Philadelphia
Stephen P HungerDepartment of Pediatrics and The Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at The University of Philadelphia
  • 1 - 8

Datasets

Release 1.2